Extreme Sensitivity of Botulinum Neurotoxin Domains Towards Mild Agitation

被引:17
作者
Toth, Stephen I. [1 ]
Smith, Leonard A. [1 ]
Ahmed, Ashraf [1 ]
机构
[1] USA, Med Res Inst Infect Dis, Dept Mol Biol, Integrated Toxicol Div, Ft Detrick, MD 21702 USA
关键词
circular dichroism; solubility; proteins; protein aggregation; surfactants; thermodynamics; enzyme; botulinum neurotoxin; precipitation; inactivation; A LIGHT-CHAIN; MECHANICAL SHAKING; THERMAL-STABILITY; AQUEOUS-SOLUTION; OXYHEMOGLOBIN-S; SEROTYPE-A; PROTEIN; AGGREGATION; DENATURATION; INHIBITORS;
D O I
10.1002/jps.21676
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Botulinum neurotoxins (BoNTs) and their fragments are targets of therapeutic developments and are increasingly used as therapeutic, prophylactic, and research reagents. However, published data on their properties vary widely. In order to gain a better understanding of these variations, we initiated a systematic investigation of the stability parameters of catalytic light chains (Lc) as well as of cell surface binding domains (Hc) of the neurotoxin. When followed by CD spectroscopy, we noticed that the recombinant light chains of serotypes A (LcA), B, D, E, and G rapidly lost their secondary structures by mild stirring. Denaturation of LcA increased with stirring speed and temperature resulting in a catalytically inactive precipitate. Reducing agents or an anaerobic environment were ineffective in the denaturation. Under identical conditions, bovine serum albumin, ovalbumin, carboxypeptidase B, and of thermolysin, a structural and functional analogue of LcA, remained unchanged. Hc domains of serotype A, 13, C, E, and F were also denatured by mild stirring. Adding the nonionic detergent Tween-20 to LcA completely prevented the denaturation. We speculate that the BoNT domains undergo surface denaturation due to rapid exposure of hydrophobic residues by mechanical agitation. This study has important implications for handling BoNT proteins used in therapeutic development. (C) 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:3302-3311, 2009
引用
收藏
页码:3302 / 3311
页数:10
相关论文
共 57 条
[1]  
ADACHI K, 1990, BLOOD, V75, P2070
[2]   Autocatalytically fragmented light chain of botulinum A neurotoxin is enzymatically active [J].
Ahmed, SA ;
McPhie, P ;
Smith, LA .
BIOCHEMISTRY, 2003, 42 (43) :12539-12549
[3]   Enzymatic autocatalysis of botulinum a neurotoxin light chain [J].
Ahmed, SA ;
Byrne, MP ;
Jensen, M ;
Hines, HB ;
Brueggemann, E ;
Smith, LA .
JOURNAL OF PROTEIN CHEMISTRY, 2001, 20 (03) :221-231
[4]   Light chain of botulinum a neurotoxin expressed as an inclusion body from a synthetic gene is catalytically and functionally active [J].
Ahmed, SA ;
Smith, LA .
JOURNAL OF PROTEIN CHEMISTRY, 2000, 19 (06) :475-487
[5]   Stability parameters for one-step mechanism of irreversible protein denaturation:: a method based on nonlinear regression of calorimetric peaks with nonzero ΔCp [J].
Arroyo-Reyna, A ;
Tello-Solís, SR ;
Rojo-Domínguez, A .
ANALYTICAL BIOCHEMISTRY, 2004, 328 (02) :123-130
[6]   ABNORMAL PRECIPITATION OF OXYHEMOGLOBIN S BY MECHANICAL SHAKING [J].
ASAKURA, T ;
OHNISHI, T ;
FRIEDMAN, S ;
SCHWARTZ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (05) :1594-1598
[7]   The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability [J].
Baldwin, MR ;
Bradshaw, M ;
Johnson, EA ;
Barbieri, JT .
PROTEIN EXPRESSION AND PURIFICATION, 2004, 37 (01) :187-195
[8]   Arg362 and Tyr365 of the botulinum neurotoxin type a light chain are involved in transition state stabilization [J].
Binz, T ;
Bade, S ;
Rummel, A ;
Kollewe, A ;
Alves, J .
BIOCHEMISTRY, 2002, 41 (06) :1717-1723
[9]   Stability of the Clostridium botulinum type a neurotoxin complex:: An empirical phase diagram based approach [J].
Brandau, Duane T. ;
Joshi, Sangeeta B. ;
Smalter, Aaron M. ;
Kim, Seonyoung ;
Steadman, Bryan ;
Middaugh, C. Russell .
MOLECULAR PHARMACEUTICS, 2007, 4 (04) :571-582
[10]   Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia [J].
Brin, MF ;
Lew, MF ;
Adler, CH ;
Comella, CL ;
Factor, SA ;
Jankovic, J ;
O'Brien, C ;
Murray, JJ ;
Wallace, JD ;
Willmer-Hulme, A ;
Koller, M .
NEUROLOGY, 1999, 53 (07) :1431-1438